Further investigation is necessary, as the differences between proHB-EGF and HB-EGF-CTF in the nucleus and the detailed mechanisms inducing cell migration are not yet fully understood; clarifying these mechanisms may result in the development of new cancer therapies. The gene discussed is EGF; the disease is cancer.